Milne Jill C. 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Milne Jill C.
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2020-02-12+150,000→ 150,000 totalExercise: $5.32Exp: 2030-02-11→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 12, 2020, and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 12, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.